Rocket Lab Bolsters Manufacturing with PCL Acquisition in New Zealand

BenzingaBenzinga
|||1 min read
Key Takeaway

Rocket Lab acquires New Zealand precision machining firm PCL to expand in-house manufacturing capabilities and support increased production of its Electron rockets and Neutron vehicle development.

Rocket Lab Bolsters Manufacturing with PCL Acquisition in New Zealand

Rocket Lab has acquired Precision Components Limited (PCL), a precision machining operation based in Auckland, New Zealand, establishing what the company is calling the Auckland Machine Complex. The strategic acquisition expands the aerospace manufacturer's in-house production capabilities for high-volume precision components used across its product portfolio, including Electron rocket systems and components for its Neutron launch vehicle under development.

The Auckland facility will integrate with Rocket Lab's existing manufacturing footprint, complementing recent expansion efforts in Tucson, Arizona. The acquisition marks the company's continued vertical integration strategy as it scales production to meet growing demand. In 2025, Rocket Lab conducted 21 Electron launches, demonstrating increased operational tempo in its commercial launch business.

The PCL acquisition positions Rocket Lab to support accelerated manufacturing schedules across its spacecraft and launch vehicle programs. By bringing precision machining capabilities in-house, the company aims to enhance supply chain control and production efficiency as it executes on plans to further increase Electron launch cadence and advance Neutron development.

Source: Benzinga

Back to newsPublished Feb 26

Related Coverage

Benzinga

Mountain Commerce Bancorp Clears Regulatory Hurdles for Home BancShares Merger

Mountain Commerce Bancorp receives Federal Reserve and Arkansas regulatory approvals for merger with Home BancShares, expected to close in early Q2 2026.

HOMBMCBI
Benzinga

Smithfield Foods Surges on Robust Q4 Earnings, Nathan's Famous Deal

Smithfield Foods beat Q4 expectations with 83-cent EPS, announced $450M Nathan's Famous acquisition at $102/share, projecting $1.3-$1.5B FY26 operating profit. Stock surged 4.13%.

SFDNATH
Benzinga

Gilead Bolsters Inflammation Arsenal With $1.675B Ouro Medicines Deal

Gilead acquires Ouro Medicines for $1.675B upfront, targeting inflammation pipeline expansion. Galapagos NV partners to co-develop lead asset OM336.

GILDACLXGLPG
Benzinga

Vertiv Accelerates Capacity Push to Capitalize on AI Data Center Boom

Vertiv expands manufacturing capacity across three facilities and acquires ThermoKey to meet soaring AI data center demand for cooling and power infrastructure.

VRTAIPO
Benzinga

SEALSQ to Acquire Quantum Interconnect Firm Miraex in Strategic Stack Play

SEALSQ signs Letter of Intent to acquire Swiss quantum interconnect firm Miraex, completing its quantum technology stack and supporting space-based quantum infrastructure initiative.

LAESWKEY
Benzinga

VGTEL Eyes Health-Tech Acquisition From 4biddenknowledge in Strategic Bell Rose Deal

VGTEL enters formal discussions with Bell Rose Capital to acquire a pre-revenue health-tech app, with due diligence underway and potential advisory role for Bell Rose's president.

VGTLBELR